|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 76.56 USD | -0.46% |
|
76.64 | +0.11% |
| 15/07 | Zoetis Inc. Launches Lenivia (Izenivetmab Injection) in Canada and the European Union | CI |
| 14/07 | Zoetis to Acquire Veterinary Teleradiology Services Platform VitalRADS | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 203.7Cr | 211.4Cr | 234.4Cr | 248.6Cr | 267.3Cr | |||||
Depreciation & Amortization - CF | 19Cr | 20Cr | 23Cr | 27Cr | 28Cr | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 20Cr | 19Cr | 18Cr | 17Cr | 16Cr | |||||
Depreciation & Amortization, Total | 40Cr | 40Cr | 42Cr | 44Cr | 44Cr | |||||
Amortization of Deferred Charges, Total - (CF) | 5.2Cr | 6.9Cr | 7.5Cr | 6.1Cr | 4.6Cr | |||||
(Gain) Loss From Sale Of Asset | 20L | - | -12Cr | 2.3Cr | 30L | |||||
Asset Writedown & Restructuring Costs | 4.7Cr | 5.3Cr | 4.6Cr | 3.1Cr | 4.7Cr | |||||
Stock-Based Compensation (CF) | 5.8Cr | 6.2Cr | 6Cr | 7.4Cr | 8.3Cr | |||||
Other Operating Activities, Total | -3.6Cr | -8.3Cr | 4.2Cr | -24Cr | 1.9Cr | |||||
Change In Accounts Receivable | -16Cr | -14Cr | -10Cr | -6.1Cr | -24Cr | |||||
Change In Inventories | -37Cr | -49Cr | -36Cr | -4Cr | -20Cr | |||||
Change In Accounts Payable | -1.7Cr | -2.9Cr | 1.3Cr | 3.1Cr | 4.6Cr | |||||
Change in Other Net Operating Assets | 20Cr | -4.7Cr | -6.2Cr | 15Cr | -1.9Cr | |||||
Cash from Operations | 221.3Cr | 191.2Cr | 235.3Cr | 295.3Cr | 290.4Cr | |||||
Capital Expenditure | -48Cr | -59Cr | -73Cr | -66Cr | -62Cr | |||||
Sale of Property, Plant, and Equipment | 20L | 10L | 40L | 10L | - | |||||
Cash Acquisitions | -1.4Cr | -31Cr | -16Cr | -80L | -2.4Cr | |||||
Divestitures | - | - | 9.6Cr | 29Cr | -40L | |||||
Investment in Marketable and Equity Securities, Total | -1.2Cr | -90L | -40L | -50L | -70L | |||||
Other Investing Activities, Total | 4.3Cr | 2.3Cr | 1.4Cr | 5.9Cr | -9.2Cr | |||||
Cash from Investing | -46Cr | -88Cr | -78Cr | -32Cr | -75Cr | |||||
Short Term Debt Issued, Total | - | 20L | 10L | - | - | |||||
Long-Term Debt Issued, Total | - | 134.8Cr | - | - | 384.8Cr | |||||
Total Debt Issued | - | 135Cr | 10L | - | 384.8Cr | |||||
Short Term Debt Repaid, Total | -40L | - | - | -30L | - | |||||
Long-Term Debt Repaid, Total | -60Cr | - | -135Cr | - | -153.7Cr | |||||
Total Debt Repaid | -60Cr | - | -135Cr | -30L | -153.7Cr | |||||
Issuance of Common Stock | - | - | 2.7Cr | - | - | |||||
Repurchase of Common Stock | -78Cr | -163.2Cr | -109.2Cr | -186.6Cr | -324.6Cr | |||||
Common Dividends Paid | -47Cr | -61Cr | -69Cr | -79Cr | -89Cr | |||||
Common & Preferred Stock Dividends Paid | -47Cr | -61Cr | -69Cr | -79Cr | -89Cr | |||||
Other Financing Activities, Total | -60L | -1.1Cr | -30L | -50L | -4.6Cr | |||||
Cash from Financing | -186.2Cr | -90Cr | -310.9Cr | -266Cr | -187Cr | |||||
Foreign Exchange Rate Adjustments | -1.2Cr | -2.9Cr | -70L | -3.2Cr | 3.9Cr | |||||
Net Change in Cash | -12Cr | 9.6Cr | -154Cr | -5.4Cr | 32Cr | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 25Cr | 24Cr | 30Cr | 27Cr | 26Cr | |||||
Cash Income Tax Paid (Refund) | 55Cr | 64Cr | 75Cr | 89Cr | 72Cr | |||||
Levered Free Cash Flow | 140.79Cr | 117.39Cr | 127.76Cr | 237.2Cr | 179.09Cr | |||||
Unlevered Free Cash Flow | 154.79Cr | 131.2Cr | 142.7Cr | 251.26Cr | 192.96Cr | |||||
Change In Net Working Capital | 18Cr | 46Cr | 31Cr | -48Cr | 28Cr | |||||
Net Debt Issued / Repaid | -60Cr | 135Cr | -134.9Cr | -30L | 231.1Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















